MeSH tree: D12.776.220.600.450
Researchers at Gladstone Institutes have discovered that a rare genetic variant known as the "Christchurch mutation" can block detrimental effects of apolipoprotein E4, the best-established risk factor for the most common ...
Nov 13, 2023
0
77
An experimental drug can reduce the toxic changes in tau proteins known to damage neurons in brains with Alzheimer's disease, researchers from Yale School of Medicine and Johns Hopkins University report.
Nov 6, 2023
0
89
There is no cure for progressive supranuclear palsy (PSP), a brain disorder marked by walking and balance difficulties. Its symptoms also mimic Parkinson's disease and dementia. The condition leads to rapid, progressive decline ...
Nov 3, 2023
0
100
An experimental version of Eisai Co's Alzheimer's drug that might be given in patients' homes exceeded the power of Leqembi, its approved infused formulation, in an early study that could pave the way to bolstering uptake.
Oct 26, 2023
0
39
Early results from PharmaKure, a pharmaceutical company spun out from The University of Manchester, shows a novel whole blood test developed by the company is able to quantify Alzheimer's disease biomarkers.
Oct 17, 2023
0
39
A team led by researchers from Mass General Brigham reports promising results for a monoclonal antibody that takes aim at a new target for Alzheimer's disease.
Oct 4, 2023
0
58
A dendritic cell vaccine administered before and after autologous stem cell transplant (ASCT) was safe and immunogenic and was associated with durable clinical responses in patients with high-risk multiple myeloma, according ...
Sep 22, 2023
0
61
A study published in PNAS Nexus identifies a molecule that may be behind cognitive symptoms, including "brain fog," experienced by those infected by the SARS-CoV-2 virus.
Sep 20, 2023
0
43
The causes of Alzheimer's disease (AD) are unclear, and the interventions for AD are very limited. However, researchers led by Prof. He Zhuohao from the Shanghai Institute of Organic Chemistry of the Chinese Academy of Sciences, ...
Sep 14, 2023
0
101
To reimagine existing preclinical trials for Alzheimer's disease, University of Pittsburgh School of Medicine neuroscientists created the first non-human primate model of hereditary Alzheimer's in marmoset monkeys, outlining ...
Sep 6, 2023
0
37
